Primer Capital is a fund investing in companies engaged in development of biotech and medical products for various pharmaceutical sectors.
Business Model:
Revenue: $20M
Employees: 51-200
Address: 48 Myasnitskaya
City: Moscow
State: moscow oblast
Zip: 107078
Country: RU
PRIMER CAPITAL is a venture capital fund focusing on investments in companies engaged in development of promising biotech and medical products for various pharmaceutical sectors. Our qualified managing Team is interested in a high-quality selection of projects that form our portfolio. Our team of qualified consultants and Scientific Advisory Board consisting of top experts in various medical, biopharmaceutical, and business fields contribute considerably to successful project selection. We cooperate with venture capital funds, business angels, government agencies interested in the development of biopharmaceutical industry, medical institutions and laboratories. Our many years’ experience and in-depth knowledge of the industry ecosystem provides portfolio companies with all opportunities for a quick start and establishment of effective relationships with their key partners throughout the whole period of its growth. Primer Capital co-invests in projects with leading venture capital funds and assists portfolio companies in fundraising.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2016 | FK Laboratoriz | Seed Round | 0 |
10/2021 | Nelo | Series A | 20M |
12/2016 | MiNDERA Corporation | Seed Round | - |
12/2016 | DataMatrix | Series A | 2.4M |
9/2017 | Bendit | Series A | 0 |
9/2020 | Athira Pharma | Convertible Note | - |
10/2017 | MT Medicals | Venture Round | - |
8/2017 | Botkin.AI | Seed Round | - |
9/2016 | Solo | Pre Seed Round | 79.5k |
3/2021 | MatriSys Bioscience | Debt | 3M |
12/2020 | Botkin.AI | Series B | 0 |
11/2017 | Gemopharm LLC | Venture Round | - |
10/2018 | MatriSys Bioscience | Seed Round | - |
1/2018 | Acticor Biotech | Series A | 0 |
10/2021 | Nelo | Series A | 0 |
3/2021 | MatriSys Bioscience | Venture Round | 0 |
12/2020 | Botkin.AI | Series B | 0 |
9/2020 | Athira Pharma | Convertible Note | - |
10/2018 | MatriSys Bioscience | Seed Round | - |
1/2018 | Acticor Biotech | Series A | 0 |
11/2017 | Gemopharm LLC | Venture Round | - |
10/2017 | MT Medicals | Venture Round | - |
9/2017 | Bendit | Series A | 0 |
8/2017 | Botkin.AI | Seed Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|